Skip to main content
Top
Published in: BMC Nephrology 1/2022

Open Access 01-12-2022 | Coronavirus | Case report

Renal artery thrombosis in SARS-CoV-2 infection: a case report

Authors: Huayan Huang, Chunguang Lin, Yongdong Chen, Xiuting Wu, Miaomiao Lin, Siqi Chen, Kai Li

Published in: BMC Nephrology | Issue 1/2022

Login to get access

Abstract

Background

Coronavirus disease 2019 (COVID-19) is identified as the pneumonia and acute respiratory distress syndrome caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV2). The intravascular thrombotic phenomena related to the COVID-19 are emerging as an important complication that contribute to significant mortality.

Case presentation

We present a 62-year-old man with severe COVID-19 and type 2 diabetes. After symptomatic and supportive treatment, the respiratory function was gradually improved. However, the patient suddenly developed abdominal pain, and the enhanced CT scan revealed renal artery thrombosis. Given the risk of surgery and the duration of the disease, clopidogrel and heparin sodium were included in the subsequent treatment. The patient recovered and remained stable upon follow-up.

Conclusions

Thrombosis is at a high risk in patients with severe COVID-19 pneumonia because of hypercoagulable state, blood stasis and endothelial injury. Thrombotic events caused by hypercoagulation status secondary to vascular endothelial injury deserves our attention. Because timely anticoagulation can reduce the risk of early complications, as illustrated in this case report.
Literature
1.
go back to reference Mukherjee A, Ghosh R. Furment MM case report: COVID-19 associated renal infarction and ascending aortic thrombosis. Am J Tropical Med. 2020;103:1989–92.CrossRef Mukherjee A, Ghosh R. Furment MM case report: COVID-19 associated renal infarction and ascending aortic thrombosis. Am J Tropical Med. 2020;103:1989–92.CrossRef
2.
go back to reference Tomasoni D, Adamo M, Italia L, Branca L, Chizzola G, Fiorina C, et al. Impact of COVID-2019 outbreak on prevalence, clinical presentation and outcomes of ST-elevation myocardial infarction. J Cardiovasc Med. 2020;21:874–81.CrossRef Tomasoni D, Adamo M, Italia L, Branca L, Chizzola G, Fiorina C, et al. Impact of COVID-2019 outbreak on prevalence, clinical presentation and outcomes of ST-elevation myocardial infarction. J Cardiovasc Med. 2020;21:874–81.CrossRef
3.
go back to reference Post A, den Deurwaarder ESG, Bakker SJL, de Haas RJ, van Meurs M, Gansevoort RT, et al. Kidney infarction in patients with COVID-19. Am J Kidney Dis. 2020;76:431–5.CrossRef Post A, den Deurwaarder ESG, Bakker SJL, de Haas RJ, van Meurs M, Gansevoort RT, et al. Kidney infarction in patients with COVID-19. Am J Kidney Dis. 2020;76:431–5.CrossRef
4.
go back to reference Basara Akin I, Altay C, Eren Kutsoylu O. Secil M possible radiologic renal signs of COVID-19. Abdom Radiol. 2021;46:692–5.CrossRef Basara Akin I, Altay C, Eren Kutsoylu O. Secil M possible radiologic renal signs of COVID-19. Abdom Radiol. 2021;46:692–5.CrossRef
5.
go back to reference Klok FA, Kruip MJHA, van der Meer NJM, Arbous MS, Gommers DAMPJ, Kant KM, et al. Incidence of thrombotic complications in critically ill ICU patients with COVID-19. Thromb Res. 2020; 2020.04.013. Klok FA, Kruip MJHA, van der Meer NJM, Arbous MS, Gommers DAMPJ, Kant KM, et al. Incidence of thrombotic complications in critically ill ICU patients with COVID-19. Thromb Res. 2020; 2020.04.013.
6.
go back to reference Lin L, Li TS. Interpretation of "guidelines for the diagnosis and treatment of novel coronavirus (2019-ncov) infection by the national health commission (trial version 5)". Zhonghua Yi Xue Za Zhi. 2020;100:E001.PubMed Lin L, Li TS. Interpretation of "guidelines for the diagnosis and treatment of novel coronavirus (2019-ncov) infection by the national health commission (trial version 5)". Zhonghua Yi Xue Za Zhi. 2020;100:E001.PubMed
7.
go back to reference Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395(10229):1054–62.CrossRef Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395(10229):1054–62.CrossRef
8.
go back to reference Arachchillage DRJ, Laffan M. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J Thrombosis, haemostasis: JTH. 2020;18(5):1233–4.CrossRef Arachchillage DRJ, Laffan M. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J Thrombosis, haemostasis: JTH. 2020;18(5):1233–4.CrossRef
9.
go back to reference Thachil J, Tang N, Gando S, Falanga A, Cattaneo M, Levi M, et al. ISTH interim guidance on recognition and management of coagulopathy in COVID-19. J Thromb Haemost. 2020;185(5):1023–6.CrossRef Thachil J, Tang N, Gando S, Falanga A, Cattaneo M, Levi M, et al. ISTH interim guidance on recognition and management of coagulopathy in COVID-19. J Thromb Haemost. 2020;185(5):1023–6.CrossRef
10.
go back to reference El Shamy O, Munoz-Casablanca N, Coca S, Sharma S, Lookstein R, Uribarri. Bilateral renal artery thrombosis in a patient with COVID-19. J Kidney medicine. 2021;3:116–9.CrossRef El Shamy O, Munoz-Casablanca N, Coca S, Sharma S, Lookstein R, Uribarri. Bilateral renal artery thrombosis in a patient with COVID-19. J Kidney medicine. 2021;3:116–9.CrossRef
11.
go back to reference Singh T, Chaudhari R. Gupta a renal artery thrombosis and mucormycosis in a COVID-19 patient. Indian J Urol. 2021;37:267–9.CrossRef Singh T, Chaudhari R. Gupta a renal artery thrombosis and mucormycosis in a COVID-19 patient. Indian J Urol. 2021;37:267–9.CrossRef
12.
go back to reference Philipponnet C, Aniort J, Chabrot P, Souweine B. Heng AE renal artery thrombosis induced by COVID-19. Clin Kidney J. 2020;13:713.CrossRef Philipponnet C, Aniort J, Chabrot P, Souweine B. Heng AE renal artery thrombosis induced by COVID-19. Clin Kidney J. 2020;13:713.CrossRef
13.
go back to reference Tang N, Bai H, Chen X, Gong J, Li D, Sun Z, et al. Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy. J Thrombosis. 2020;18(5):1094–9.CrossRef Tang N, Bai H, Chen X, Gong J, Li D, Sun Z, et al. Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy. J Thrombosis. 2020;18(5):1094–9.CrossRef
14.
go back to reference Varga Z, Flammer AJ, Steiger P, Haberecker M, Andermatt R, Zinkernagel AS, et al. Endothelial cell infection and endotheliitis in COVID-19. Lancet. 2020;395(10234):1417–8.CrossRef Varga Z, Flammer AJ, Steiger P, Haberecker M, Andermatt R, Zinkernagel AS, et al. Endothelial cell infection and endotheliitis in COVID-19. Lancet. 2020;395(10234):1417–8.CrossRef
15.
go back to reference Ferrario CM, Jessup J, Chappell MC, Averill DB, Brosnihan KB, Tallant EA, et al. Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2. Circulation. 2005;111(20):2605–10.CrossRef Ferrario CM, Jessup J, Chappell MC, Averill DB, Brosnihan KB, Tallant EA, et al. Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2. Circulation. 2005;111(20):2605–10.CrossRef
16.
go back to reference Meduri GU, Kohler G, Headley S, Tolley E, Stentz F, Postlethwaite A. Inflammatory cytokines in the BAL of patients with ARDS. Persistent elevation over time predicts poor outcome. Chest. 1995;108(5):1303–14.CrossRef Meduri GU, Kohler G, Headley S, Tolley E, Stentz F, Postlethwaite A. Inflammatory cytokines in the BAL of patients with ARDS. Persistent elevation over time predicts poor outcome. Chest. 1995;108(5):1303–14.CrossRef
17.
go back to reference José RJ, Williams AE, Chambers RC. Proteinase-activated receptors in fibroproliferative lung disease. Thorax. 2014;69(2):190–2.CrossRef José RJ, Williams AE, Chambers RC. Proteinase-activated receptors in fibroproliferative lung disease. Thorax. 2014;69(2):190–2.CrossRef
Metadata
Title
Renal artery thrombosis in SARS-CoV-2 infection: a case report
Authors
Huayan Huang
Chunguang Lin
Yongdong Chen
Xiuting Wu
Miaomiao Lin
Siqi Chen
Kai Li
Publication date
01-12-2022
Publisher
BioMed Central
Published in
BMC Nephrology / Issue 1/2022
Electronic ISSN: 1471-2369
DOI
https://doi.org/10.1186/s12882-022-02808-5

Other articles of this Issue 1/2022

BMC Nephrology 1/2022 Go to the issue